AJP - Endo AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 293: E1224-E1232, 2007. First published August 21, 2007; doi:10.1152/ajpendo.00279.2007
0193-1849/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/5/E1224    most recent
00279.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horner, K. C.
Right arrow Articles by Sauze, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horner, K. C.
Right arrow Articles by Sauze, N.

Experimental estrogen-induced hyperprolactinemia results in bone-related hearing loss in the guinea pig

Kathleen C. Horner,1 Yves Cazals,1 Régis Guieu,2 Marc Lenoir,3 and Nicole Sauze2

1Centre National de la Recherche Scientifique UMR 6153, Institut National de la Recherche Agronomique 1147, Université Paul Cézanne; 2Centre National de la Recherche Scientifique FRE 2738, Université de la Méditerranée, Marseille; and 3Institut National de la Santé et de la Recherche Médicale, Unité 583, Montpellier, France

Submitted 3 May 2007 ; accepted in final form 10 August 2007

Our group (Horner KC, Guieu R, Magnan J, Chays A, Cazals Y. Neuropsychopharmacology 26: 135–138, 2002) has earlier described hyperprolactinemia in some patients presenting inner ear dysfunction. However, in that study, it was not possible to determine whether hyperprolactinemia was a cause or an effect of the symptoms. To investigate the effect of hyperprolactinemia on inner ear function, we first developed a model of hyperprolactinemia in estrogen-primed Fischer 344 rats and then performed functional studies on pigmented guinea pigs. Hyperprolactinemia induced, after 2 mo, a hearing loss of ~30–40 dB across all frequencies, as indicated by the compound action potential audiogram. During the 3rd mo, the hearing loss continued to deteriorate. The threshold shifts were more substantial in males than in females. Observations under a dissection microscope revealed bone dysmorphology of the bulla and the cochlea. Light microscopy observations of cryostat sections confirmed bone-related pathology of the bony cochlear bulla and the cochlear wall and revealed morphopathology of the stria vascularis and spiral ligament. Scanning electron microscopy revealed loss of hair cells and stereocilia damage, in particular in the upper three cochlear turns and the two outermost hair cell rows. The data provide the first evidence of otic capsule and hair cell pathology associated with estrogen-induced prolonged hyperprolactinemia and suggest that conditions such as pregnancy, anti-psychotic drug treatment, aging, and/or stress might lead to similar ear dysfunctions.

hormones; deafness; prolactin; estrogen; osteoprotegerin



Address for reprint requests and other correspondence: K. C. Horner, CNRS UMR 6153-1147 INRA, Université Paul Cézanne, Faculté des Sciences et Techniques, Campus St Jérôme, Cases 351 352, Ave. Escadrille Normandie Niémen, 13397 Marseille Cedex 20, France (e-mail: kathleen.horner{at}univ-cezanne.fr)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.